Prothena Corp PLC (STU:0PT)
€ 16.4 0.1 (0.61%) Market Cap: 881.85 Mil Enterprise Value: 370.47 Mil PE Ratio: 0 PB Ratio: 1.62 GF Score: 76/100

Q4 2023 Prothena Corporation PLC Earnings Call Transcript

Feb 15, 2024 / 09:30PM GMT
Release Date Price: €25.4 (+3.25%)
Operator

Good day, ladies and gentlemen, and welcome to the Prothena's Biosciences' fourth quarter and full-year 2023 financial results conference call. My name is Krista, and I will be your coordinator for today. (Operator Instructions) I would now like to turn the presentation over to Mark Johnson, Vice President of Investor Relations at Prothena. Please proceed.

Mark Johnson
Prothena Corporation plc - VP, Investor Relations

Thank you, operator. Good afternoon, everyone, and welcome to today's call to review Prothena's business progress fourth quarter and full-year 2023 financial results and 2024 financial guidance. Please review the press release we issued earlier today, which is available on our website at prothena.com and is also attached to a Form 8-K filed today with the SEC. In addition, we are using supplemental slides which are available on our investor website's events and presentations section.

On today's call, Dr. Gene Kinney, our President and Chief Executive Officer will provide opening remarks including an overview of Prothena's corporate and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot